Virtus Investment Advisers
Virtus Investment Advisers reported 458 stocks worth $453M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MRNA (1.4%), IOVA (1.4%) and REGN (0.9%). Compared with Q2 2026, the fund opened new positions in OKTA, HPE and PANW, added to MRNA, IOVA and REGN, trimmed MRVL, AMD and MU and sold out of ILMN, CAT and RCL.
Latest filing: what Virtus Investment Advisers did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MRNA Moderna Inc | $6.5M | 1.4% | 34K | +10K (+45%) | 7 of 8 | |
| 2 | ![]() IOVA Iovance Biotherapeutics Inc | $6.1M | 1.4% | 413K | +128K (+45%) | 7 of 8 | |
| 3 | ![]() REGN Regeneron Pharmaceutical | $4.2M | 0.9% | 5,490 | +1,170 (+27%) | 7 of 8 | |
| 4 | ![]() GILD Gilead Sciences Inc | $4.1M | 0.9% | 28K | +4,219 (+18%) | 7 of 8 | |
| 5 | ![]() AMGN Amgen Inc | $4M | 0.9% | 9,586 | +1,014 (+12%) | 7 of 8 | |
| 6 | ![]() VRTX Vertex Pharmaceuticals I | $4M | 0.9% | 7,668 | +5,054 (+193%) | 7 of 8 | |
| 7 | ![]() OMER Omeros Corp | $3.7M | 0.8% | 193K | +60K (+45%) | 5 of 8 | |
| 8 | ![]() INCY Incyte Corp | $3.7M | 0.8% | 30K | +633 (+2%) | 7 of 8 | |
| 9 | ![]() BMRN Biomarin Pharmaceutical Inc | $3.6M | 0.8% | 61K | +40K (+192%) | 7 of 8 | |
| 10 | ![]() VSTM Verastem Inc | $3.3M | 0.7% | 411K | +127K (+45%) | 4 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() ILMN Illumina Inc | $2.5M | 14K |
![]() CAT Caterpillar Inc | $2.3M | 2,173 |
![]() RCL Royal Caribbean Group | $2.2M | 6,961 |
![]() HOOD Robinhood Mkts Inc | $2.2M | 21K |
![]() URI United Rentals Inc | $2.1M | 1,877 |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 12, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Virtus Investment Advisers 13F FAQ
What does Virtus Investment Advisers own?
Virtus Investment Advisers reported 458 stocks worth $453M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MRNA (1.4%), IOVA (1.4%) and REGN (0.9%). The table above lists every position in the filing (the top 10 without an account).
What did Virtus Investment Advisers buy and sell in Q3 2026?
Compared with Q2 2026: 45 new positions, 186 added to, 225 trimmed and 50 sold out. New positions include OKTA, HPE and PANW. It sold all of ILMN, CAT and RCL.
When will Virtus Investment Advisers file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Virtus Investment Advisers's portfolio worth?
The Q3 2026 filing reports $453M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.

























